Difference between revisions of "Suramin (Antrypol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 12: | Line 12: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Intravenous medications]] | ||
[[Category:Antiparasitic]] | [[Category:Antiparasitic]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 12:35, 27 July 2023
Mechanism of action
Antiparasitic with mechanism of action unclear.
Diseases for which it was used
History of changes in FDA indication
- This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.
Also known as
- Brand name: Antrypol